Form 4: United Therapeutics Director Tommy G. Thompson Executes Stock Option and Sells Shares
SEC Form 4 Filing
Director Tommy G. Thompson exercised stock options and sold shares of United Therapeutics Corp on June 26, 2024.
Summary
- On June 26, 2024, Tommy G. Thompson, a director of United Therapeutics Corp, exercised stock options to acquire 7,500 shares of common stock at a price of $175.43 per share.
- Following the exercise of options, Thompson sold a total of 7,500 shares in multiple transactions.
- The sales were executed at weighted average prices of $318.8122 for 5,085 shares, $320.2118 for 1,515 shares, and $320.8383 for 900 shares.
- After these transactions, Thompson directly owns 10,895 shares of common stock and indirectly owns 5,800 shares through a Family LLC and 8,200 shares through a Trust.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing detailing stock transactions, with no inherent positive or negative sentiment.
Industry Context
This Form 4 filing is a routine disclosure of insider transactions, providing transparency to the market regarding the trading activities of company directors.
Stakeholder Impact
- The transactions may have a minor impact on shareholders due to the director's stock sales, but the overall effect is likely minimal.
Key Dates
| Date | Description |
|---|---|
| 06/26/2016 | Original date of stock options that were exercised. |
| 06/26/2024 | Date of stock option exercise and share sales. |
| 06/26/2025 | Expiration date of stock options. |
| 06/27/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.